Clinical Trials Logo

Failure to Thrive clinical trials

View clinical trials related to Failure to Thrive.

Filter by:

NCT ID: NCT02842645 Completed - Clinical trials for Mental Health Disorder

Growth-Health and Development in Children Exposed to Drugs During Pregnancy

Start date: February 2011
Phase: N/A
Study type: Observational

"Children exposed to alcohol or drugs during pregnancy: Growth, health and development" Background Children exposed to drugs during pregnancy are at risk of developmental disorders. The scope and size of this problem is poorly known in Norway. Alcohol has a known teratogenic effect on the fetus. How other drugs affect the fetus, is associated with more uncertainty. Withdrawal in the neonatal period has been perceived as the main problem. There is less knowledge about long-term outcome of exposure to drugs during pregnancy. Aim The aim of the study is to investigate the physical and mental health of children exposed to drugs during pregnancy. Identify the children's need for measures in the home and school, and how many of the children who are taken care of in fostercare. A sample of the children will be offered radiological examination of the brain (f-MRI). The purpose is to study the relationship between exposure to drugs, child development, environment and organic brain dysfunction. Design The project is a quantitative study. The relationship between exposure to drugs and development will be measured by questionnaires, clinical examination, neuropsychological tests and radiological examination (f-MRI). Children aged 2-15years who were referred, examined or treated for drug related problems at the Department of Pediatrics, Haukeland University Hospital will be invited to participate in the study. Information retrieval and examination of the children are expected to be completed during 2011. Data analysis and further processing of data are expected to be completed during 2013.

NCT ID: NCT02819401 Completed - GI Tolerance Clinical Trials

The Effects of a High-fiber Formula in Children With Failure to Thrive

Start date: February 2013
Phase: N/A
Study type: Observational

The present study is designed to determine the gastrointestinal tolerability of enteral nutritional products, physicians and parents' overall perception of enteral nutrition products as well as providing basic demographic information on pediatric populations prescribed these formula for supportive treatment as part of the routine healthcare service in Turkey.

NCT ID: NCT02657629 Completed - Clinical trials for Hypoplastic Left Heart Syndrome

Comparison of Feeding Strategies for Hypoplastic Left Heart Syndrome Infants

Start date: December 2009
Phase: N/A
Study type: Interventional

The purpose of the study is to determine if a continuous feeding regimen as compared to an intermittent bolus feeding regimen leads to improved weight gain in infants with hypoplastic left heart syndrome (HLHS) after stage 1 procedures.

NCT ID: NCT02647580 Completed - Failure to Thrive Clinical Trials

Appetite Regulation in Children With Failure to Thrive

Start date: December 2015
Phase: N/A
Study type: Observational

Failure to thrive (FTT) is an expression for inadequate growth in the early childhood and thus, a sign of undernutrition. This study will include children with FTT, and compare with existing data from children with normal and excessive growth. The overall aim of this study is to explore whether 1) children who develop FTT with no organic explanation differ from healthy normal weight and overweight children in their basal level of appetite-regulating hormones and 2) if inadequate, normal and excessive growth in children can be partly predicted by variation in their gut microbiome and metabolome.

NCT ID: NCT02515266 Completed - Premature Birth Clinical Trials

Additional Protein Fortification in Extremely Low Birth Weight Infants

PROTSUP
Start date: May 2015
Phase: N/A
Study type: Observational

Postnatal growth is a crucial in premature infants as it could be correlated with the long-term cognitive development. Optimal nutritional care is required to reduce the initial weight loss and further growth deficit. The quantitative objective is to achieve growth that is at least equivalent to that of the fetus (on average 15 g/kg.day (12-18 g/kg.day according to gestational age). Children often grow during difficult 10-15 first days of life, so they accumulate a delay that should compensate them secondarily. Therefore, optimum postnatal growth is rather 20 g/kg.day than 15 g/kg.day. Individualized fortification of human milk (HM) has been proposed to optimize postnatal growth. Specifically, the lack of protein intake is responsible for sub-optimal postnatal growth in preterm infants. The objectives of this study are to determine the effectiveness of additional protein fortification (APF) in terms of short-term growth along with the proportion of extremely low birth weight (ELBW) infants requiring APF.

NCT ID: NCT02419599 Completed - Growth Failure Clinical Trials

High vs Standard Energy Children's Drink Study

Start date: August 2015
Phase: N/A
Study type: Interventional

This study is a pilot trial investigating the effects of a high energy drink for children, in comparison to standard energy drink for children.

NCT ID: NCT02136966 Completed - Growth Failure Clinical Trials

Joint Infant and Young Child Nutrition Program and Malnutrition Prevention

Start date: November 2014
Phase: N/A
Study type: Interventional

Study title: Joint Infant and young children nutrition program in Burkina Faso: Impact evaluation Hypothesis: The fortification of complementary foods associated with a counseling on feeding practices for infants and young children prevents malnutrition in 6-23 months-old children. Objective: to assess the effectiveness of a promotional care package in preventing malnutrition among children aged 6-23 months.

NCT ID: NCT02128984 Completed - Cystic Fibrosis Clinical Trials

Clinical Study With an Enteral Formula With Symbiotic and DHA for Malnourished Children

VITJUNIOR
Start date: January 2012
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether a nutritional supplement is effective in the treatment of malnutrition in pediatric patients with failure to thrive or cystic fibrosis.

NCT ID: NCT01909661 Completed - Tolerance Clinical Trials

Tolerance of Infants With Cow's Milk Protein Allergy to Extensively Hydrolyzed Rice Protein or Casein Infant Formulas

JUNGLO
Start date: March 2013
Phase: Phase 2
Study type: Interventional

The objective of this double blinded randomized study is to assess the tolerance of two extensively protein hydrolyzed infant formulas, one based on rice protein and the other one on casein, at introduction, and after 3 months of consumption, and their efficacy on growth and on the reduction of allergy symptoms through a 3 months consumption period.

NCT ID: NCT01883193 Completed - Mortality Clinical Trials

Women First: Preconception Maternal Nutrition

WF
Start date: August 2013
Phase: N/A
Study type: Interventional

Multi-country three-arm, individually randomized, non-masked, controlled trial to ascertain the benefits of ensuring optimal maternal nutrition before conception and providing an evidence base for programmatic priority directed to minimizing the risk of malnutrition in all females of reproductive age.